Notice on soliciting opinions on 38 pharmaceutical excipient standards including docusate sodium and other materials to be included in the Chinese Pharmacopoeia

All relevant units:

In accordance with the "Chinese Pharmacopoeia" preparation plan, our committee organized relevant units to formulate and revise some pharmaceutical excipient standards.

According to the "Chinese Pharmacopoeia" medicinal excipients selection principle (pharmaceutical excipients that have been used in domestic and foreign preparations and whose safety has been confirmed), the relevant pharmaceutical excipient manufacturers and users are invited to give feedback on the proposed new standards The following information: The company produces or uses the pharmaceutical excipients, when the pharmaceutical excipients have been applied to which domestically marketed preparations, and how safe are the excipients and preparations

Relevant pharmaceutical excipient manufacturers and users are requested to provide feedback on the proposed new and revised standards: whether the company believes that the draft standard is applicable to the production or use of pharmaceutical excipients, reasons for inapplicability, and whether there are other suggestions

All relevant associations are requested to widely publicize among member units, and relevant companies are invited to give feedback in time, and submit relevant opinions and suggestions to our committee in writing before December 1, 2021, with relevant instructions, experimental data and contact information

Contact: Chen Lei, Kang Xiaobo

Phone: 010-67079566, 67079620

Email: 475@chp.

Mailing address: Office of the National Pharmacopoeia Commission, Building 11, Fahua South Lane, Dongcheng District, Beijing

Post Code: 100061